Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System

Bhagelu R Achyut, Nadimpalli Ravi S Varma, Ali S Arbab

Research output: Contribution to journalArticle

Abstract

Umbilical cord blood (UCB) derived multipotent stem cells are capable of giving rise hematopoietic, epithelial, endothelial and neural progenitor cells. Thus suggested to significantly improve graft-versus-host disease and represent the distinctive therapeutic option for several malignant and non-malignant diseases. Recent advances in strategies to isolate, expand and shorten the timing of UCB stem cells engraftment have tremendously improved the efficacy of transplantations. Nervous system has limited regenerative potential in disease conditions such as cancer, neurodegeneration, stroke, and several neural injuries. This review focuses on application of UCB derived stem/progenitor cells in aforementioned pathological conditions. We have discussed the possible attempts to make use of UCB therapies to generate neural cells and tissues with developmental and functional similarities to neuronal cells. In addition, emerging applications of UCB derived AC133+ (CD133+) endothelial progenitor cells (EPCs) as imaging probe, regenerative agent, and gene delivery vehicle are mentioned that will further improve the understanding of use of UCB cells in therapeutic modalities. However, safe and effective protocols for cell transplantations are still required for therapeutic efficacy.

Original languageEnglish (US)
JournalJournal of stem cell research & therapy
Volume4
DOIs
StatePublished - Jan 20 2015
Externally publishedYes

Fingerprint

Nervous System Diseases
Fetal Blood
Stem Cells
Blood Cells
Multipotent Stem Cells
Cell Transplantation
Graft vs Host Disease
Therapeutics
Nervous System
Transplantation
Stroke
Wounds and Injuries
Genes
Neoplasms

Cite this

Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System. / Achyut, Bhagelu R; Varma, Nadimpalli Ravi S; Arbab, Ali S.

In: Journal of stem cell research & therapy, Vol. 4, 20.01.2015.

Research output: Contribution to journalArticle

@article{ce00a8602f154ee699426da60ba1f894,
title = "Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System",
abstract = "Umbilical cord blood (UCB) derived multipotent stem cells are capable of giving rise hematopoietic, epithelial, endothelial and neural progenitor cells. Thus suggested to significantly improve graft-versus-host disease and represent the distinctive therapeutic option for several malignant and non-malignant diseases. Recent advances in strategies to isolate, expand and shorten the timing of UCB stem cells engraftment have tremendously improved the efficacy of transplantations. Nervous system has limited regenerative potential in disease conditions such as cancer, neurodegeneration, stroke, and several neural injuries. This review focuses on application of UCB derived stem/progenitor cells in aforementioned pathological conditions. We have discussed the possible attempts to make use of UCB therapies to generate neural cells and tissues with developmental and functional similarities to neuronal cells. In addition, emerging applications of UCB derived AC133+ (CD133+) endothelial progenitor cells (EPCs) as imaging probe, regenerative agent, and gene delivery vehicle are mentioned that will further improve the understanding of use of UCB cells in therapeutic modalities. However, safe and effective protocols for cell transplantations are still required for therapeutic efficacy.",
author = "Achyut, {Bhagelu R} and Varma, {Nadimpalli Ravi S} and Arbab, {Ali S}",
year = "2015",
month = "1",
day = "20",
doi = "10.4172/2157-7633.1000202",
language = "English (US)",
volume = "4",
journal = "Journal of stem cell research & therapy",
issn = "2157-7633",

}

TY - JOUR

T1 - Application of Umbilical Cord Blood Derived Stem Cells in Diseases of the Nervous System

AU - Achyut, Bhagelu R

AU - Varma, Nadimpalli Ravi S

AU - Arbab, Ali S

PY - 2015/1/20

Y1 - 2015/1/20

N2 - Umbilical cord blood (UCB) derived multipotent stem cells are capable of giving rise hematopoietic, epithelial, endothelial and neural progenitor cells. Thus suggested to significantly improve graft-versus-host disease and represent the distinctive therapeutic option for several malignant and non-malignant diseases. Recent advances in strategies to isolate, expand and shorten the timing of UCB stem cells engraftment have tremendously improved the efficacy of transplantations. Nervous system has limited regenerative potential in disease conditions such as cancer, neurodegeneration, stroke, and several neural injuries. This review focuses on application of UCB derived stem/progenitor cells in aforementioned pathological conditions. We have discussed the possible attempts to make use of UCB therapies to generate neural cells and tissues with developmental and functional similarities to neuronal cells. In addition, emerging applications of UCB derived AC133+ (CD133+) endothelial progenitor cells (EPCs) as imaging probe, regenerative agent, and gene delivery vehicle are mentioned that will further improve the understanding of use of UCB cells in therapeutic modalities. However, safe and effective protocols for cell transplantations are still required for therapeutic efficacy.

AB - Umbilical cord blood (UCB) derived multipotent stem cells are capable of giving rise hematopoietic, epithelial, endothelial and neural progenitor cells. Thus suggested to significantly improve graft-versus-host disease and represent the distinctive therapeutic option for several malignant and non-malignant diseases. Recent advances in strategies to isolate, expand and shorten the timing of UCB stem cells engraftment have tremendously improved the efficacy of transplantations. Nervous system has limited regenerative potential in disease conditions such as cancer, neurodegeneration, stroke, and several neural injuries. This review focuses on application of UCB derived stem/progenitor cells in aforementioned pathological conditions. We have discussed the possible attempts to make use of UCB therapies to generate neural cells and tissues with developmental and functional similarities to neuronal cells. In addition, emerging applications of UCB derived AC133+ (CD133+) endothelial progenitor cells (EPCs) as imaging probe, regenerative agent, and gene delivery vehicle are mentioned that will further improve the understanding of use of UCB cells in therapeutic modalities. However, safe and effective protocols for cell transplantations are still required for therapeutic efficacy.

U2 - 10.4172/2157-7633.1000202

DO - 10.4172/2157-7633.1000202

M3 - Article

C2 - 25599002

VL - 4

JO - Journal of stem cell research & therapy

JF - Journal of stem cell research & therapy

SN - 2157-7633

ER -